Antilia Pharma Private Limited - Company Profile

It is a trading private limited company based in Sangli, Maharashtra, India, established in 2018.
2018 Sangli, Maharashtra, India Active
Last Updated:
Access Report
About Antilia Pharma Private Limited

Antilia Pharma Private Limited, a active private limited company, was established on 16 March 2018 in Sangli, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909PN2018PTC175428. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.

It upholds a compliant status. Employing 6 professional, Its leadership includes Shaliwahan Vishwanath Pattanshetti (Director), Vinayak Kiran Patole (Managing Director), Mohiddin Ismail Mujawar (Whole-Time Director). Past directors included Shaliwahan Vishwanath Pattanshetti, Vinayak Kiran Patole, Mohiddin Ismail Mujawar. It holds ₹1.25 M open charges and no settled loans. Its latest AGM occurred on 25 July 2025, with the balance sheet filed on 31 March 2025. It is based at S.No. 4887/2/3 Rajnagar, Chintamaninagar, Sangli., Sangli, Maharashtra, 416416.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909PN2018PTC175428

  • Registration Number

    175428

  • Incorporation Date

    16 March 2018

  • Authorized Capital

    ₹3.00 M

  • Paid-Up Capital

    ₹3.00 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 M
  • Paid Up Capital ₹ 3.00 M
  • Company Age 7 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.25 M
Company report

Antilia Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Antilia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Antilia Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Shaliwahan Vishwanath Pattanshetti Director 30 Jan 2019 Current
Vinayak Kiran Patole Managing Director 16 Mar 2018 Current
Mohiddin Ismail Mujawar Whole-Time Director 16 Mar 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 18 Oct 2019 Past
Pramod Abcsdd Director 24 Jan 2019 Past
Pramod Abcsdd Director 24 Jan 2019 Past
Pramod Abcsdd Director 24 Jan 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Antilia Pharma.

Antilia Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Antilia Pharma revenue growth over time
Antilia Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Antilia Pharma?

Unlock access to Antilia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,250,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 0.13 Cr
Latest Charge Details
Date Lender Amount Status
30 May 2024 Others ₹1.25 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Antilia Pharma?

Antilia Pharma has a workforce of 6 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Antilia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antilia Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Antilia Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Antilia Pharma Private Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Antilia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.25 M with Charge ID 100937838 was registered on 30 May 2024. was documented.

  • Director Appointment

    Shaliwahan Vishwanath Pattanshetti was appointed as a Director was appointed as a Director on 30 Jan 2019 & has been associated with this company since 7 years 17 days . was recorded as a recent event.

  • Director Appointment

    Vinayak Kiran Patole was appointed as a Managing Director was appointed as a Managing Director on 16 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

  • Director Appointment

    Mohiddin Ismail Mujawar was appointed as a Whole-time director was appointed as a Whole-time director on 16 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Antilia Pharma Private Limited?

The CIN of Antilia Pharma Private Limited is U51909PN2018PTC175428.

Where is Antilia Pharma Private Limited headquartered?

Antilia Pharma Private Limited is headquartered at S.No. 4887/2/3 Rajnagar, Chintamaninagar, Sangli., Sangli, Maharashtra, 416416.

When was Antilia Pharma Private Limited incorporated?

Antilia Pharma Private Limited was incorporated on 16 March 2018.

Who are the current directors of Antilia Pharma Private Limited?

The current directors of Antilia Pharma Private Limited are

What is the primary industry of Antilia Pharma Private Limited?

The primary industry of Antilia Pharma Private Limited is Trading.

Is Antilia Pharma Private Limited a listed company?

Antilia Pharma Private Limited is unlisted.

What is the capital structure of Antilia Pharma Private Limited?

The authorized capital of Antilia Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.

What is the compliance status of Antilia Pharma Private Limited?

The compliance status of Antilia Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available